President and Chief Executive Officer
John Danner joined Codon Devices as President and CEO in November 2005. He has more than 15 years of leadership experience in a variety of technology-oriented organizations. Mr. Danner was most recently with PerkinElmer, Inc., where he held a number of executive positions in business development and general management. From 2003 to 2005, he was Vice President and General Manager of a $450M group of biopharmaceutical tools businesses.
Prior to his tenure at PerkinElmer, Mr. Danner was a consultant with McKinsey & Company, serving in both the United States and Europe, focusing on strategy development, operational excellence, and organizational restructuring. Previously, he served as an Officer in the U.S. Navy's nuclear submarine force. Mr. Danner holds a B.S. with distinction in engineering from Cornell University and an MBA with distinction from the Wharton School at the University of Pennsylvania.
Chief Scientific Officer and Founder
Dr. Baynes co-founded Codon Devices in 2004 while a Venture Associate with Flagship Ventures. He was responsible for Codon’s day-to-day operations and led development of the BioFAB ™ Platform through the company’s first revenue recognition in late 2005. Now as Chief Scientific Officer, Dr. Baynes focuses on research and development, external collaborations, and applications strategy.
Prior to joining Codon Devices, Dr. Baynes was an engineer in process automation and composition modeling at Mobil Oil and a Station Director in the MIT School of Chemical Engineering Practice at Mitsubishi Chemicals and General Mills. He has also worked closely with several biotech startup companies including Agrivida, BG Medicine, Compound Therapeutics, and Epitome Biosystems.
Dr. Baynes did his PhD research in protein stabilization with Bernhardt Trout and Danny Wang at MIT. For this work he received the W. H. Peterson Award from the American Chemical Society, the Serge N. Timasheff Award from the University of Colorado, and two MIT departmental research awards.
Senior Vice President, Technical Operations
Mr. Muir brings more than 20 years of technology development, implementation and application experience from several biopharmaceutical and biotechnology settings. Most recently, he held a number of executive positions, including Vice-President of Platform Technology at Millennium Pharmaceuticals Inc. During his 12-year tenure with MPI, Mr. Muir led efforts in technology programs including proteomics, functional genomics, imaging, and applied mass spectrometry. In addition, to these programs Mr. Muir led the build, development, and integration of a high-throughput, quality-focused synthetic DNA facility; a key enabler of MPI’s genomics infrastructure and a model template for a new synthetic capability for Codon Devices' mission. Additionally, Mr. Muir’s organization developed novel bioassay instrumentation and assay systems in areas of cardiovascular medicine, oncology and functional genomics.
Mr. Muir’s practical experience and invention skills in material science, robotics, nucleic acid technology, microfluidics and process integration will help Codon Devices further the development and operation of its powerful BioFAB™ capabilities over the short and long term.
Prior to his Millennium experience, Mr. Muir developed and applied automation, robotics and bioassay development to drug discovery and biotechnology at Tularik (now Amgen), Genentech, and the University of Vermont.
Jennifer A. Camacho
Vice President of Intellectual Property and Chief Patent Counsel
Jennifer Camacho joined Codon Devices in August of 2005. Prior to joining Codon, she practiced law in the Boston office of a large New York law firm and, before that, in a large Boston law firm. Her practice included all aspects of strategic patent counseling, litigation and alternative dispute resolution, patent infringement and validity analyses, patentability and product clearance studies, patent prosecution and patent interference proceedings.
Ms. Camacho has extensive experience in licensing and other transactional matters such as joint development, sponsored research and acquisition. She has represented public and private companies, as well as academic institutions, hospitals and non-profit organizations. She has published articles in both technical and legal journals, and is a frequent lecturer on topics related to intellectual property. Ms. Camacho's legal publications include several articles in The Journal of BioLaw & Business and Intellectual Property Observer.
She received her J.D. from Boston College Law School and is admitted to the Bar in Massachusetts and the U.S. District Court, District of Massachusetts. She is also registered to practice before the U.S. Patent and Trademark Office.
Michael J. Fitzpatrick
Vice President, Sales
Before joining Codon Devices, Mr. Fitzpatrick held multiple executive sales roles at AB, including Vice President of Global Key Accounts, Vice President of Sales and Support for the Molecular Biology Division and Vice President, The Americas. He was accountable for as much as $1.1 billion of revenue and a global customer base across academic, biotechnology and pharmaceutical market segments.
Senior Director, Marketing
Ms. Notchey joined Codon Devices in September 2006. Coming from PerkinElmer Inc. where she led the $100M Life Science Research Business Unit, Ms. Notchey has over 15 years of experience in the life sciences industry. While at PerkinElmer, Ms. Notchey held multiple leadership roles and covered a broad portfolio of reagent and instrument products in various capacities, including marketing, product management, sales and service.
Prior to joining PerkinElmer, Ms. Notchey was at Endogen, Inc. where she led the product management, technical support and customer service organizations. Ms. Notchey also performed signal transduction research in the lab of Tom Roberts at the Dana Farber Cancer Institute.
She holds a B.S. with honors in Microbiology from the University of Massachusetts and Certification in the Greater Boston Executive Program from the M.I.T. Sloan School of Management.